0

Emricasan

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP254750022
CAS254750-02-2
Structure
MDL NumberMFCD11840420
Molecular Weight569.50
Description≥98% (HPLC)
SolubilityDMSO: 2 mg/mL, clear
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions−20°C
1

An Update on the Recent Advances in Antifibrotic Therapy

Frank Tacke, Ralf Weiskirchen

Expert Rev Gastroenterol Hepatol. 2018 Nov;12(11):1143-1152.

PMID: 30261763

1

Current and Future Pharmacological Therapies for NAFLD/NASH

Yoshio Sumida, Masashi Yoneda

J Gastroenterol. 2018 Mar;53(3):362-376.

PMID: 29247356

1

Current and Upcoming Pharmacotherapy for Non-Alcoholic Fatty Liver Disease

Yaron Rotman, Arun J Sanyal

Gut. 2017 Jan;66(1):180-190.

PMID: 27646933

1

Exquisite Sensitivity of Adrenocortical Carcinomas to Induction of Ferroptosis

Alexia Belavgeni, Stefan R Bornstein, Anne von Mässenhausen, Wulf Tonnus, Julian Stumpf, Claudia Meyer, Evelyn Othmar, Markus Latk, Waldemar Kanczkowski, Matthias Kroiss, Constanze Hantel, Christian Hugo, etc.

Proc Natl Acad Sci U S A. 2019 Oct 29;116(44):22269-22274.

PMID: 31611400

1

Identification of Small-Molecule Inhibitors of Zika Virus Infection and Induced Neural Cell Death via a Drug Repurposing Screen

Miao Xu, Emily M Lee, Zhexing Wen, Yichen Cheng, Wei-Kai Huang, Xuyu Qian, Julia Tcw, Jennifer Kouznetsova, Sarah C Ogden, Christy Hammack, Fadi Jacob, Ha Nam Nguyen, Misha Itkin, Catherine Hanna, Paul Shinn, etc.

Nat Med. 2016 Oct;22(10):1101-1107.

PMID: 27571349

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode